Key result
Wistar-Furth rats do not develop proteinuria or significant renal injury after chronic nitric oxide synthase inhibition at doses that cause significant injury in Sprague Dawley rats.
Why the study?
Does chronic nitric oxide synthase inhibition cause renal injury in Wistar-Furth rats compared to Sprague Dawley rats?
Does chronic nitric oxide synthase inhibition cause renal injury in Wistar-Furth rats compared to Sprague Dawley rats?
Wistar-Furth rats are resistant to renal injury from chronic nitric oxide synthase inhibition, a protection that may be mediated by resistance to glomerular hypertension.
Answers are grounded in this paper and cite their sources.
Rat strain differences in NOS inhibition renal injury caution against model generalization to humans; leaves open genetic modifiers of CKD susceptibility.
Chronic nitric oxide synthase inhibition (NOSI) causes chronic kidney disease (CKD) in the Sprague Dawley (SD) rat. We previously showed that the Wistar-Furth (WF) rats are resistant to several models of CKD and maintain renal nitric oxide (NO) production compared with SD rats, whereas low-dose NOSI caused progression of CKD in WF rats. Here, we evaluate the impact of high-dose chronic NOSI in WF and SD rats, as well as intrarenal responses to an acute pressor dose of NOSI in the normal WF. Rats were given N(G)-nitro-l-arginine methyl ester (l-NAME) (150 and 300 mg/l for 6-10 wk) in the drinking water after an initial bolus tail vein injection. Both strains showed significant reductions in total NO production with chronic l-NAME. SD given 150 mg/l l-NAME for 6 wk developed proteinuria and renal injury, whereas WF rats receiving 150 mg/l l-NAME for 6-10 wk or 300 mg/l for 6 wk developed no proteinuria and minimal renal injury. Blood pressure was significantly elevated with chronic NOSI in both strains but was higher in the SD rat. There was little impact on renal nitric oxide synthase expression with l-NAME, except that cortical endothelial nitric oxide synthase abundance increased in WF after 6 wk (150 mg/l). Micropuncture experiments with acute pressor NOSI resulted in similar increases in systemic blood pressure in SD and WF rats, whereas WF rats showed a much smaller increment in glomerular blood pressure compared with SD rats. In conclusion, WF rats do not develop renal injury after chronic NOSI at, or above, a dose that causes significant injury in the SD rat. This protection may be associated with protection from glomerular hypertension.
No takes yet. Share an insight, caveat, or question.
Erdely et al. (2005) studied Chronic kidney disease. N(G)-nitro-l-arginine methyl ester (l-NAME) vs. Sprague Dawley rats was evaluated on Proteinuria and renal injury. Wistar-Furth rats do not develop proteinuria or significant renal injury after chronic nitric oxide synthase inhibition at doses that cause significant injury in Sprague Dawley rats.
Synapse has enriched 10 related papers. Consider them for comparative context: